Canaan | Investor Profile

Portfolio companies

Canaan is on record against 58 companies.

Abyrx Aceiss Acesion Pharma ApS Actio Biosciences, Inc. ACTIVE Network ActualyzeAI, Inc. Advanced BioHealing Aer Therapeutics, Inc. Aeva Agomab Therapeutics Aim Security AirEye Alkymi Alphina Therapeutics Alsius Corporation AlterEgo Networks Alterome Therapeutics, Inc. Altimate Inc. Ambra Health Amicus Therapeutics Antiva Biosciences Apartment List Apex.AI Apieron apisec.ai Appsmith Arbor Arbor Networks Arcade Archipelago Argon Networks Arrakis Therapeutics Artie Arvinas Associated Content Astra AtheroMed Attotude Inc. Autobahn Therapeutics, Inc. Axcelius I/II Axis Security Azibo Basebuild, Inc. Beckon Bellhop Berkshire Grey Bev Binarly BiPar Sciences, Inc. Bird Blurb Bond Bravo Sierra Brigit Bumblebee Spaces Bumped Buzzer Bzaar

Investment focus

Canaan invests across all stages globally, from seed to growth, with a focus on technology sectors including enterprise software, healthtech, and fintech. The firm operates internationally, with a strong emphasis on the United States market.

Related investors

Canaan PartnersAlso backs Autobahn Therapeutics, Inc. and Bravo Sierra and 56 more of the same companies
Airbus VenturesAlso backs Apex.AI and Astra
Flourish VenturesAlso backs Brigit
YL VenturesAlso backs Aim Security
RET VenturesAlso backs Azibo

All investors with a sourced record →

Get a deep full report on Canaan → Get warm-intro paths to Canaan → See how VCs use MentionFox →